Schematic diagram of monitoring points and units. by Jie Zhao (49409)

“…Results demonstrate that unreinforced foundations exhibit systematic residual deformation due to liquefaction-induced sand flow, which is significantly reduced by gravel pile reinforcement. Both excess pore water pressure and pore pressure ratio decrease markedly after reinforcement. …”

Model monitoring points and units coordinates. by Jie Zhao (49409)

“…Results demonstrate that unreinforced foundations exhibit systematic residual deformation due to liquefaction-induced sand flow, which is significantly reduced by gravel pile reinforcement. Both excess pore water pressure and pore pressure ratio decrease markedly after reinforcement. …”

Variables, the Time Points Collected, and the Number of Nurses Who Responded. by Rachel G. Baskin (22127334)

Subjects:

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Immunogenicity results of different vaccination schemes at different time points. by Rima Moghnieh (679199)

Subjects:

(a) Histogram of relative phase at all steps for all participants. by Shinnosuke Hase (20917896)

The Karolinska Sleepiness Scale (KSS) is a 9-point Likert scale, ranging from “extremely 1 = alert” to “9 = extremely sleepy–fighting sleep” [44]. by Marcel F. Hinss (14675457)

Multi-organ differential gene expression changes statistically significant at hypertension onset. by Eden Hornung (20148295)

The importance of entry criteria from the point of view of the SD method ‐ combination A. by Roman Vavrek (13200141)

Average % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for brown non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked. by Indrani Bera (804948)

“…<p>Average % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for brown non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked. by Indrani Bera (804948)

“…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”

Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects: